• Aucun résultat trouvé

Blood meal and blood products detection using Synchronous fluorescence spectroscopy

N/A
N/A
Protected

Academic year: 2021

Partager "Blood meal and blood products detection using Synchronous fluorescence spectroscopy"

Copied!
1
0
0

Texte intégral

(1)

Context: The use of animal by-products (including processed animal proteins, PAPs) depends of their nature defined by the cell type and the species of origin. Currently, their detection is based on two methods: light microscopy and PCR. Complementary methods are needed to be developed in order to refine the by-products identification.

Objective: The aim of this work[1] was to develop a fast and easy method to detect blood meal and blood products. This study was based on the detection of hemoglobin in animal feed by synchronous fluorescence spectroscopy (SFS).

Materials & Method

3. Screening on commercial feed (protein extracts*):

Walloon Agricultural Research Centre

Valorisation of Agricultural Products Department

Food and Feed Quality Unit

www.cra.wallonie.be

Blood meal and blood products detection using

Synchronous fluorescence spectroscopy

Lecrenier M.C.

1

, Abbas O.

1

, Taira A.

2

, Arnould Q.

1

& Baeten V.

1

1Food and Feed Quality Unit of Agricultural Product Valorisation Department - CRA-W, Belgium;

2Catholic University of Louvain - UCL, Louvain-la-Neuve, Belgium.

m.lecrenier@cra.wallonie.be; FoodFeedQuality@cra.wallonie.be

1. Optimization of the SFS

conditions on reference materials: • Hemoglobin powder

• Albumin powder

2. Validation on feed materials (protein extracts*):

• Hemoglobin powder (n = 8) • Blood meal (n = 3)

• Plasma powder (n = 2)

3. Screening on commercial feed (protein extracts*):

• Feed with plasma powder

• Feed with hemoglobin powder / blood meal • Feed without any blood derived products

1. Optimization of the SFS conditions on reference materials: Wavelength range 300 - 600 nm

Excitation/Emission slits 5.5 nm / 6 nm Hemoglobin concentration 3 µM

Offset 17 nm

Solvent DIGE Labelling Buffer (DLA)

2. Validation on feed materials (protein extracts*):

- DLA bands are present at 360 nm and 406 nm.

- Hemoglobin bands are present at 484 nm and 538 nm.

- Bands of hemoglobin are present in blood meal

samples.

- Plasma powder doesn’t

contain hemoglobin. It has the same spectral profile as DLA.

*Protein extraction by TCA/aceton precipitation following by resuspension in DLA[2]

- Hemoglobin spectral bands are present in feed known to contain hemoglobin powder or blood meal.

- Feed containing plasma powder don’t show hemoglobin spectral bands.

- Feed without blood derived products don’t present hemoglobin spectral bands; however four of them have an additional spectral band at 454 nm (unknown compound).

- Principal Component Analysis on normalized area SFS spectra allows the distribution of samples based on the presence of hemoglobin. Samples containing hemoglobin are located in the negative part of PC2 while the positive part of PC1 permits to distinguish two groups of feed without blood.

Theses results confirmed that SFS is a promising screening method for the detection of hemoglobin in animal feed. Moreover, the method could also be used to evaluate hemoglobin extraction yield in support to other analytical methods.

[1] Taira, A. et al. (2016) Processed animal proteins detection using Fluorescence spectroscopy. Master Thesis .

[2] Lecrenier, M.C. et al. (2016) Identification of specific bovine blood biomarkers with a non-targeted approach using HPLC ESI tandem mass spectrometry. Food Chemistry, 213, 417-424.

Introduction

Results

Conclusion et perspectives

Références

Documents relatifs

New Car- diovascular Indices Based on a Nonlinear Spectral Analysis of Arterial Blood Pressure Waveforms.. [Research Report]

(6) to develop, provide and disseminate guidance and technical support to strengthen national coordinated blood and plasma programmes and introduction of blood component

Recalling resolution WHA58.13 on blood safety: proposal to establish World Blood Donor Day and preceding related resolutions since resolution WHA28.72 on utilization and supply

Working with countries to create sustainable blood and plasma programmes with appropriate regulatory systems will contribute to the following public health benefits: (a) optimal use

(b) improved safety and quality of blood products; (c) appropriate clinical use of blood products and safe transfusion practices; (d) sustainable and affordable supply of

(2) to advise and build capacity in Member States on leadership and management of blood supply systems in order to strengthen national coordinated and sustainable blood and

Moreover, the Indonesian regulatory authority for medical products, the National Agency for Drug and Food Control, had publicly indicated its commitment to enforcing

NBI audits local plasma suppliers to monitor and improve quality and safety standards that meet NBI’s requirements. Over the past 10–15 years this process has contributed to